文章摘要
五皮饮治疗乳腺癌术后上肢淋巴水肿的临床研究
Clinical Study on Wupiyin in the Treatment of Upper Limb Lymphedema after Breast Cancer Surgery
投稿时间:2026-06-11  修订日期:2026-06-11
DOI:
中文关键词: Clinical Study on Wupiyin in the Treatment of Upper Limb Lymphedema after Breast Cancer Surgery
英文关键词: Wupiyin  Breast Cancer  Postoperative Complications  Upper Extremity Lymphedema  Clinical Efficacy  Traditional Chinese Medicine Treatment
基金项目:武威市科技计划项目(编号:WW24B01SF036)
作者单位邮编
俞登峰 甘肃省武威肿瘤医院 733000
李应宏* 甘肃省武威肿瘤医院 
王金燕 甘肃省武威肿瘤医院 
何才庆 甘肃省武威肿瘤医院 
刘文林 甘肃省武威肿瘤医院 
王莉 甘肃省武威肿瘤医院 
罗梅 甘肃省武威肿瘤医院 
苏灵林 甘肃省武威肿瘤医院 
摘要点击次数: 1580
全文下载次数: 0
中文摘要:
  目的 探讨五皮饮治疗乳腺癌术后上肢淋巴水肿的临床疗效、安全性及对患者生活质量的影响,为临床治疗该病提供中医诊疗依据。方法 研究对象为2024年1月至2025年12月于我院就诊的80例乳腺癌术后并发上肢淋巴水肿患者。所有病例均严格遵循纳入与剔除标准筛选,再以随机数字表法均分两组,每组各40例。单纯予以常规西医治疗为对照组,观察组在此基础上配合五皮饮口服,两组治疗时长均为4周。比较两组患者治疗前后患侧上肢周径、患-健侧上肢周径差、中医证候积分、上肢功能障碍评分(Disability of the Arm, Shoulder and Hand,DASH)、视觉模拟疼痛评分(Visual Analogue Scale,VAS)及生活质量(Quality of Life,QOL)评分,统计两组临床疗效及不良反应发生情况。结果 治疗后,观察组患侧上肢周径、患-健侧周径差、中医证候积分、DASH评分、VAS评分及QOL评分均优于对照组(P<0.05)。对照组 40 例患者中 30 例治疗有效,有效率 75.00%;观察组有效病例 37 例,有效率 92.50%,组间差异显著(P<0.05)。观察组与对照组不良反应发生率分别为 5.00%、7.50%,组间对比未见明显统计学差异(P>0.05)。结论 五皮饮治疗乳腺癌术后上肢淋巴水肿疗效确切,能有效减轻患侧上肢水肿,改善患者中医证候及上肢功能,缓解疼痛,提高生活质量,且安全性良好。
英文摘要:
    Objective To explore the clinical efficacy, safety and influence on quality of life of Wupiyin in the treatment of upper extremity lymphedema after breast cancer surgery, and to provide TCM diagnosis and treatment basis for clinical treatment of the disease. Methods The subjects of this study were 80 patients with upper limb lymphedema after breast cancer surgery who were treated in our hospital from January 2024 to December 2025. All cases were strictly screened according to the inclusion and exclusion criteria, and then divided into two groups by random number table method, 40 cases in each group. The control group was treated with conventional western medicine alone, and the observation group was treated with Wupiyin orally on this basis. The treatment duration of the two groups was 4 weeks.The circumference of the affected upper extremity, the circumference difference between the affected and healthy upper extremities, TCM syndrome score, Disability of the Arm, Shoulder and Hand (DASH) score, Visual Analogue Scale (VAS) score and Quality of Life (QOL) score were compared between the two groups before and after treatment. The clinical efficacy and adverse reactions of the two groups were counted. Results After treatment, The circumference of the affected upper limb, the circumference difference between the affected side and the healthy side, TCM syndrome score, DASH score, VAS score and QOL score in the observation group were better than those in the control group(P<0.05). Among the 40 patients in the control group, 30 achieved effective treatment, with an effective rate of 75.00%. In the observation group, 37 cases were effective, corresponding to an effective rate of 92.50%. There was a significant difference between the two groups (P<0.05). The incidence of adverse reactions in the observation group and the control group were 5.00 % and 7.50 %, respectively, and there was no significant statistical difference between the two groups(P>0.05). Conclusion Wupiyin has a definite curative effect in the treatment of upper extremity lymphedema after breast cancer surgery. It can effectively reduce the edema of the affected upper extremity, improve the TCM syndrome and upper extremity function of patients, relieve pain, improve quality of life, and has good safety.
  下载PDF阅读器  HTML全文
关闭

文章摘要
  
DOI:
中文关键词: 
英文关键词: 
基金项目:
摘要点击次数:
全文下载次数:
中文摘要:
  
英文摘要:
    
  下载PDF阅读器  HTML全文
关闭